Articles Tagged With: vaginal
-
Is Vaginal Carbon Dioxide Laser an Effective Treatment for the Genitourinary Syndrome of Menopause?
In this double-blinded, randomized controlled trial, fractional carbon dioxide vaginal laser was no better than sham laser in improving Female Sexual Function Index scores among 72 breast cancer survivors on aromatase inhibitors over a six-month period.
-
Ibrexafungerp Tablets (Brexafemme)
Ibrexafungerp can be prescribed to treat adults and post-menarchal pediatric females with vulvovaginal candidiasis.
-
What Is the Optimal Mode of Delivery of the Second Twin?
In this randomized clinical trial, 343 pregnant women with twin gestations were randomized to planned cesarean delivery and planned vaginal delivery groups (208 patients vs. 135 patients, respectively) between October 2013 and March 2015. The cesarean delivery rate in the planned vaginal delivery arm was 49% compared to the cesarean rate of 99% in the planned cesarean delivery arm. If all criteria for vaginal delivery are met, it would be reasonable and appropriate to offer women with diamniotic twin gestations planned vaginal delivery between 34 0/7 to 37 6/7 weeks of gestation.
-
A New Nonhormonal Vaginal Gel Contraceptive
In this single-arm, open-label, Phase III study of a novel vaginal pH regulator gel among 1,384 sexually active women aged 18 to 35 years, the seven-cycle cumulative pregnancy rate was 13.7% (95% confidence interval, 10.0% to 17.5%).
-
A New Treatment for Recurrent Bacterial Vaginosis?
Recurrent bacterial vaginosis is a problem that affects many women, with an estimated 50% of women developing a recurrence within 12 months of treatment. The authors of this study tested the efficacy of a novel product, Lactobacillus crispatus CTV-05 (Lactin-V), in reducing bacterial vaginosis recurrence in this phase 2b clinical trial.
-
Apical Suspension at the Time of Vaginal Hysterectomy
The main objective of this study was to determine whether the use of apical suspension at the time of vaginal hysterectomy varies by surgeon specialty.
-
Is Vaginal Progestogen Equivalent to Intramuscular Progestogen for Preventing Preterm Birth in High-Risk Women?
In this open-label, equivalence randomized trial of vaginal progestogen compared to intramuscular progestogens for preventing preterm birth in high-risk women, the difference in the risk of preterm birth at < 37 weeks of gestation between both groups was 3.1% (95% confidence interval, -7.6% to 13.8%), which was within the equivalence margin of 15% used in the study.
-
A New Treatment for Recurrent Bacterial Vaginosis?
In this randomized, controlled trial of 228 women, Lactobacillus crispatus CTV-05 (Lactin-V) applied vaginally for 11 weeks reduced the incidence of recurrent bacterial vaginosis from 45% in the placebo arm to 30% in the Lactin-V arm.
-
Vaginal Dryness: The Keystone Symptom of Postmenopausal Sexual Dysfunction?
In a large, cross-sectional, multicenter study in Italy that evaluated factors predictive of sexual dysfunction, vaginal dryness correlated independently and negatively with each Female Sexual Function Index domain.
-
Long-Lasting, Woman-Controlled Contraception Is Here
Annovera is designed for 21 days of continuous use, followed by a seven-day ring-free interval, during which the ring is removed, washed, and stored. Unlike other products, the same ring is used for subsequent cycles for an entire year (13 cycles total).